Q1 2020 13F Holders as of 31 Mar 2020
-
Type / Class
-
Equity / SPONSORED ADS
-
Number of holders
-
9
-
Total 13F shares, excl. options
-
7,339,905
-
Shares change
-
-376,660
-
Total reported value, excl. options
-
$49,030,000
-
Value change
-
-$2,479,416
-
Number of buys
-
2
-
Number of sells
-
-9
-
Price
-
$6.68
Significant Holders of Innate Pharma SA - SPONSORED ADS (IPHA) as of Q1 2020
13 filings reported holding IPHA - Innate Pharma SA - SPONSORED ADS as of Q1 2020.
Innate Pharma SA - SPONSORED ADS (IPHA) has 9 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 7,339,905 shares
.
Largest 10 shareholders include EcoR1 Capital, LLC (4,465,668 shares), WELLINGTON MANAGEMENT GROUP LLP (1,334,110 shares), Rubric Capital Management LP (931,673 shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (500,000 shares), MILLENNIUM MANAGEMENT LLC (72,657 shares), OXFORD ASSET MANAGEMENT LLP (29,397 shares), MORGAN STANLEY (3,300 shares), Advisor Group Holdings, Inc. (2,000 shares), Steward Partners Investment Advisory, LLC (1,100 shares), and Maven Securities LTD (0 shares).
This table shows the top 9 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.